DERIVATIVE LIABILITIES (Tables)

9 Months Ended

Dec. 31, 2021

Debt Instrument [Line Items]

SCHEDULE OF DERIVATIVE LIABILITIES

	Total $
Derivative liabilities as at March 31, 2020	1,144,733
Derivative fair value at issuance during fiscal 2021	41,749
Change in fair value of derivatives	(776,440	)
Derivative liabilities as at March 31, 2021	410,042
Change in fair value of derivatives during the period	(203,525	)
Derivative liabilities as at June 30, 2021	206,517
Derivative fair value at issuance during three months ended September 30, 2021	17,084
Change in fair value of derivatives during the period	(101,773	)
Derivative liabilities as at September 30, 2021	121,828
Reduction due to preferred shares redeemed / converted	(479,791	)
Change in fair value of derivatives during the period	644,774
Derivative liabilities as at December 31, 2021	286,811

SCHEDULE OF DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS

The lattice methodology was used to value the derivative components, using the following assumptions for the three months ended December 31, 2021:

	Assumptions
Dividend yield		12	%
Risk-free rate for term		0.40% - 0.77	%
Volatility		116.4% - 101.3	%
Remaining terms (Years)		2.33 to 4.00
Stock price ($   per share)	$	2.91 to $4.33

Convertible Debt [Member]

Debt Instrument [Line Items]

SCHEDULE OF DERIVATIVE LIABILITIES

	Total
		$
For the year ended March 31, 2021
Derivative fair value at issuance
Series A notes (Note 5(b))		6,932,194
Series B notes (Note 5(b))		497,042
		7,429,236
Fair value change upon end of warrants derivative treatment (Note 5(b))		(82,444	)
Carrying amount of warrants liability transferred into equity upon end of warrants derivative treatment (Note 5(b))		(3,937,664	)
Conversion to common shares (Note 5(b))		(225,284	)
Change in fair value of derivative liabilities		450,012
Balance at March 31, 2021		3,633,856
For the three months ended June 30, 2021
Conversion to common shares (Note 5(b))		(403,108	)
Change in fair value of derivative liabilities		502,508
Balance at June 30, 2021		3,733,256
For the three months ended September 30, 2021
Conversion to common shares (Note 5(b))		(2,744,711	)
Change in fair value of derivative liabilities		(295,801	)
Balance at September 30, 2021		692,744
For the three months ended December 31, 2021
Conversion to common shares (Note 5(b))		(250,738	)
Change in fair value of derivative liabilities		129,999
Balance at December 31, 2021		572,005

SCHEDULE OF DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS

The monte-carlo methodology was used to value the convertible note and warrant derivative components, using the following assumptions for the three months ended December 31, 2021:

	Conversion and redemption features
Risk-free rate for term (%)	0.29 – 0.39
Volatility (%)	78.0 – 83.3
Remaining terms (Years)	0.02 – 0.29
Stock price ($   per share)	3.98 – 4.53